Items where Author is "Arababadi, M.K."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.


Asadikaram, G. and Meimand, H.A.E. and Noroozi, S. and Sanjari, M. and Zainodini, N. and Arababadi, M.K. (2020) The effect of IFN-β 1a on expression of MDA5 and RIG-1 in multiple sclerosis patients. Biotechnology and Applied Biochemistry.

Asadikaram, G. and Noroozi, S. and Meimand, H.A.E. and Sanjari, M. and Zainodini, N. and Khoramdelazad, H. and Shahrokhi, N. and Arababadi, M.K. (2017) Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients. NeuroImmunoModulation.

Allahtavakoli, M. and Moloudi, R. and Arababadi, M.K. and Shamsizadeh, A. and Javanmardi, K. (2009) Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat. Brain Research, 1271. pp. 121-127.

This list was generated on Mon Apr 12 20:52:07 2021 EDT.